Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03341975 · ClinicalTrials.gov registry record · NA
Enhanced SexHealth Intervention to Improve Adolescent Outcomes
A NA study of Sexually Transmitted Diseases and Reproductive Behavior, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT03341975: Completed NA study of Sexually Transmitted Diseases and Reproductive Behavior, sponsored by Children's Mercy Hospital Kansas City.
NCT03341975 is a NA study of Sexually Transmitted Diseases and Reproductive Behavior that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 91 participants, below the 1,248-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03341975, a NA study of Sexually Transmitted Diseases and Reproductive Behavior, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an adaptive trial with an initial Formative Revision Process followed by a Randomized Controlled Trial (RCT). Up to 500 adolescents will be consented into this study to achieve 6 completed subjects for the formative process and 86 completed subjects for the RCT.
Primary Outcome
Any 1 or more of the following services: Testing for pregnancy, gonorrhea/chlamydia, and/or HIV, hormonal birth control, condoms, emergency contraception (for immediate or future use), treatment for previously diagnosed (yet untreated) infection with gonorrhea/chlamydia, appointment for clinic referral.
Conditions Studied
Interventions
- BEHAVIORAL SexHealth
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2020-05-01 |
| Phase | NA |
What the finished NCT03341975 record still lists
NCT03341975 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,248-participant average among 35 other Sexually Transmitted Diseases trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Sexually Transmitted Diseases appearing as the primary indexed condition, and to 1 intervention - of which SexHealth is the first listed.
NCT03341975 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03341975 about?
NCT03341975 is a clinical study titled "Enhanced SexHealth Intervention to Improve Adolescent Outcomes". This is an adaptive trial with an initial Formative Revision Process followed by a Randomized Controlled Trial (RCT). Up to 500 adolescents will be consented into this study to achieve 6 completed subjects for the formative process and 86 completed subjects for the RCT.
What is the current status of trial NCT03341975?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2017-12-01. Estimated completion is 2020-05-01.
What conditions does trial NCT03341975 study?
This clinical trial studies the following conditions: Sexually Transmitted Diseases, Reproductive Behavior.
What interventions are being tested in trial NCT03341975?
The interventions under investigation include: SexHealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT03341975?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03341975 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexually Transmitted Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03341975's enrollment target sits among peer trials
91 30th of 35 higher than 6 of 35 other Sexually Transmitted Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexually Transmitted Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
RECRUITING · NA
-
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
RECRUITING · NA
-
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI